Global Health Limited Financial Ratios
MEDANTA · Healthcare · Current price ₹1,238.6
P/E ratio
59.8x
P/B ratio
9.9x
ROE
14.0%
ROCE
15.4%
Debt / Equity
0.30
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 59.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 9.9x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 14.0% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 15.4% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.30 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Global Health Limited's latest numbers.
Global Health Limited profitability
Global Health Limited generates a return on equity of 14.0% and a return on capital employed of 15.4%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.30 and a P/E of 59.8x, Global Health Limited is conservatively financed. Our overall business-quality score for the company is 4.7 / 10.
Understand the ratios
More on Global Health Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.